| Dr Jacques Abi Rached, MD | |
|
207 Kings Hwy S Ste 2, Cherry Hill, NJ 08034-2508 | |
| (856) 616-8600 | |
| Not Available |
| Full Name | Dr Jacques Abi Rached |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 18 Years |
| Location | 207 Kings Hwy S Ste 2, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790920577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 25MA09676200 (New Jersey) | Primary |
| 207R00000X | Internal Medicine | MD449269 (Pennsylvania) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Access Care Of Sp Llc | 2365411469 | 7 |
News Archive
Amedica Corporation, an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the release of its silicon nitride lateral lumbar interbody fusion device.
Excessive alcohol consumption, as well as obesity leads to the accumulation of fat in the liver, a disease termed fatty liver disease (FLD) or steatosis. FLD is one of the most prevalent diseases in Western societies and affects about 30% of the adult population. Importantly, FLD increases the risk of liver failure, diabetes and cancer and no pharmacological therapies exist for this detrimental disease.
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
CMC Biologics, Inc., a global CMO dedicated to process development and production of biopharmaceuticals for clinical and commercial use, today announced that it will supply bulk drug substance for Emergent BioSolutions' recently FDA-approved product, IXINITY® [coagulation factor IX (recombinant)].
› Verified 1 days ago
| Entity Name | American Access Care Of Pennsylvania Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063487627 PECOS PAC ID: 0143213132 Enrollment ID: O20040406000529 |
News Archive
Amedica Corporation, an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the release of its silicon nitride lateral lumbar interbody fusion device.
Excessive alcohol consumption, as well as obesity leads to the accumulation of fat in the liver, a disease termed fatty liver disease (FLD) or steatosis. FLD is one of the most prevalent diseases in Western societies and affects about 30% of the adult population. Importantly, FLD increases the risk of liver failure, diabetes and cancer and no pharmacological therapies exist for this detrimental disease.
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
CMC Biologics, Inc., a global CMO dedicated to process development and production of biopharmaceuticals for clinical and commercial use, today announced that it will supply bulk drug substance for Emergent BioSolutions' recently FDA-approved product, IXINITY® [coagulation factor IX (recombinant)].
› Verified 1 days ago
| Entity Name | American Access Care Of Sp Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588639819 PECOS PAC ID: 2365411469 Enrollment ID: O20040927000284 |
News Archive
Amedica Corporation, an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the release of its silicon nitride lateral lumbar interbody fusion device.
Excessive alcohol consumption, as well as obesity leads to the accumulation of fat in the liver, a disease termed fatty liver disease (FLD) or steatosis. FLD is one of the most prevalent diseases in Western societies and affects about 30% of the adult population. Importantly, FLD increases the risk of liver failure, diabetes and cancer and no pharmacological therapies exist for this detrimental disease.
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
CMC Biologics, Inc., a global CMO dedicated to process development and production of biopharmaceuticals for clinical and commercial use, today announced that it will supply bulk drug substance for Emergent BioSolutions' recently FDA-approved product, IXINITY® [coagulation factor IX (recombinant)].
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jacques Abi Rached, MD Po Box 416210, Boston, MA 02241-6210 Ph: (610) 644-8900 | Dr Jacques Abi Rached, MD 207 Kings Hwy S Ste 2, Cherry Hill, NJ 08034-2508 Ph: (856) 616-8600 |
News Archive
Amedica Corporation, an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, is pleased to announce the release of its silicon nitride lateral lumbar interbody fusion device.
Excessive alcohol consumption, as well as obesity leads to the accumulation of fat in the liver, a disease termed fatty liver disease (FLD) or steatosis. FLD is one of the most prevalent diseases in Western societies and affects about 30% of the adult population. Importantly, FLD increases the risk of liver failure, diabetes and cancer and no pharmacological therapies exist for this detrimental disease.
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
CMC Biologics, Inc., a global CMO dedicated to process development and production of biopharmaceuticals for clinical and commercial use, today announced that it will supply bulk drug substance for Emergent BioSolutions' recently FDA-approved product, IXINITY® [coagulation factor IX (recombinant)].
› Verified 1 days ago
Shagufta Ahsan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003 Phone: 917-808-5942 | |
Dr. Alexandr Zaslavsky, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-406-0023 | |
Dr. Tolulope Adesiyun Agunbiade, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034 Phone: 856-482-8900 | |
Garo Charles Avetian, D.O. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003 Phone: 856-761-8100 Fax: 856-761-8107 | |
Matthew Everwine, DO Nephrology Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-513-4124 | |
Dr. Behjath Jafry, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034 Phone: 856-428-6616 Fax: 856-428-4823 | |
William C Groh, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034 Phone: 856-216-0300 |